Masahide Fukudo

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Combination Therapy

Pseudomonas Aeruginosa

Atrial Fibrillation

Metastatic Renal Cell Carcinoma

Top Venues

Journal of pharmaceutical health care and sciences

Investigational new drugs

Journal of clinical pharmacology

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Yusuke Kunimoto, Shinichi Hikasa, Masashi Ishihara, Mariko Tsukiji, Kazuko Nobori, Takeshi Kimura, Kenta Onishi, Yuuki Yamamoto, Kyohei Haruta, Yohei Kasiwabara, Kenji Fujii, Masahide Fukudo
Factors associated with incomplete adherence to integrase strand transfer inhibitor-containing single-tablet regimen among Japanese people living with HIV. Journal of pharmaceutical health care and sciences 10 (1) (2024)
Yusuke Kunimoto, Shinichi Hikasa, Masashi Ishihara, Mariko Tsukiji, Kazuko Nobori, Takeshi Kimura, Kenta Onishi, Yuuki Yamamoto, Kyohei Haruta, Yohei Kasiwabara, Kenji Fujii, Masahide Fukudo
Factors associated with incomplete adherence to integrase strand transfer inhibitor-containing single-tablet regimen among Japanese people living with HIV. Journal of pharmaceutical health care and sciences 10 (1) (2024)
Yusuke Kunimoto, Ryosuke Matamura, Hiroshi Ikeda, Hiroto Horiguchi, Satoshi Fujii, Masayoshi Kobune, Masahide Fukudo, Takaki Toda
Adherence of denosumab treatment for low bone mineral density in Japanese people living with HIV: a retrospective observational study. Journal of pharmaceutical health care and sciences 9 (1) (2023)
Takashi Kato, Yusuke Kunimoto, Manabu Kitagawa, Yuichiro Asai, Tomoko Kimyo, Hiromasa Nakata, Mamoru Takahashi, Hirofumi Chiba, Hiroki Takahashi, Atsushi Miyamoto, Masahide Fukudo
Drug interactions between ALK inhibitors and warfarin with concurrent use of bucolome: a case report. Journal of pharmaceutical health care and sciences 9 (1) (2023)
Yuta Ibe, Ryuichiro Kakizaki, Hirotoshi Inamura, Tomoyuki Ishigo, Yoshihiro Fujiya, Hiroyuki Inoue, Shuji Uemura, Satoshi Fujii, Satoshi Takahashi, Eichi Narimatsu, Masahide Fukudo
Tazobactam/ceftolozane and tobramycin combination therapy in extensively drug-resistant Pseudomonas aeruginosa infections in severe burn injury: a case report. Journal of pharmaceutical health care and sciences 9 (1) (2023)
Yuta Ibe, Tomoyuki Ishigo, Satoshi Fujii, Sataoshi Takahashi, Masahide Fukudo, Hideki Sato
Simulation of Vancomycin Exposure Using Trough and Peak Levels Achieves the Target Area under the Steady-State Concentration-Time Curve in ICU Patients. Antibiotics (Basel, Switzerland) 12 (7) (2023)
Takashi Kato, Yusuke Kunimoto, Manabu Kitagawa, Yuichiro Asai, Tomoko Kimyo, Hiromasa Nakata, Mamoru Takahashi, Hirofumi Chiba, Hiroki Takahashi, Atsushi Miyamoto, Masahide Fukudo
Drug interactions between ALK inhibitors and warfarin with concurrent use of bucolome: a case report. Journal of pharmaceutical health care and sciences 9 (1) (2023)
Tomohiro Aigami, Tomoyuki Ishigo, Ryo Takada, Toshiyuki Yano, Masayuki Koyama, Satoshi Katano, Satoshi Fujii, Masahide Fukudo
Comparison of the Treatment Persistence Among 4 Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A 5-Year Retrospective Cohort Study. Journal of clinical pharmacology (2023)
Takashi Kato, Yusuke Kunimoto, Manabu Kitagawa, Yuichiro Asai, Tomoko Kimyo, Hiromasa Nakata, Mamoru Takahashi, Hirofumi Chiba, Hiroki Takahashi, Atsushi Miyamoto, Masahide Fukudo
Drug interactions between ALK inhibitors and warfarin with concurrent use of bucolome: a case report. Journal of pharmaceutical health care and sciences 9 (1) (2023)
Tomohiro Aigami, Tomoyuki Ishigo, Ryo Takada, Toshiyuki Yano, Masayuki Koyama, Satoshi Katano, Satoshi Fujii, Masahide Fukudo
Comparison OF The Treatment Persistence Among Four Direct Oral Anticoagulants In Patients With Non-Valvular Atrial Fibrillation: A 5-Year Retrospective Cohort Study. Journal of clinical pharmacology (2023)
Masahide Fukudo, Kei Ishibashi, Masahiro Kitada
Real-world pharmacokinetics and pharmacodynamics of everolimus in metastatic breast cancer. Investigational new drugs 39 (6) (2021)
Masahide Fukudo, Keiko Asai, Chikayoshi Tani, Masashi Miyamoto, Katsuyoshi Ando, Nobuhiro Ueno
Pharmacokinetics of the oral multikinase inhibitor regorafenib and its association with real-world treatment outcomes. Investigational new drugs 39 (5) (2021)
Masahide Fukudo, Ryota Ishikawa, Kazuto Mishima, Takashi Ono, Seiji Matsumoto, Yoshikazu Tasaki
Real-World Nivolumab Wastage and Leftover Drug Stability Assessment to Facilitate Drug Vial Optimization for Cost Savings. JCO oncology practice 16 (10) (2020)
Masahide Fukudo, Gaku Tamaki, Makoto Azumi, Hiroaki Shibata, Susumu Tandai
Pharmacokinetically guided dosing has the potential to improve real-world outcomes of pazopanib. British journal of clinical pharmacology 87 (4) (2020)
Masahide Fukudo, Gaku Tamaki, Makoto Azumi, Hidehiro Kakizaki, Seiji Matsumoto, Yoshikazu Tasaki
Absorption of the orally active multikinase inhibitor axitinib as a therapeutic index to guide dose titration in metastatic renal cell carcinoma. Investigational new drugs 39 (2) (2020)